215 related articles for article (PubMed ID: 1771528)
1. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
[No Abstract] [Full Text] [Related]
2. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
3. [Hemorheologic risk profile in peripheral arterial occlusive disease, diabetic angiopathy and essential arterial hypertension].
Sternitzky R; Wiederhold KF; Hänsgen K; Jäger H; Turowski A; Voigt H
Vasa Suppl; 1991; 32():325-31. PubMed ID: 1771526
[No Abstract] [Full Text] [Related]
4. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Pöhlmann G; Braumann A; Grohmann G
Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
[No Abstract] [Full Text] [Related]
5. [Effect of hemodilution on systemic and capillary hematocrit].
Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
[TBL] [Abstract][Full Text] [Related]
6. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
Sternitzky R; Hänsgen K; Podhaisky H
Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
[TBL] [Abstract][Full Text] [Related]
7. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
8. [Clinical aspects of hemorheology in the aged].
Staedt U; Heene DL
Internist (Berl); 1991 Aug; 32(8):447-52. PubMed ID: 1938264
[No Abstract] [Full Text] [Related]
9. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
10. [Hemodilution in cerebral ischemia. Farewell to a common treatment concept].
Back T; von Kummer R
Dtsch Med Wochenschr; 1989 Mar; 114(9):350-4. PubMed ID: 2646096
[No Abstract] [Full Text] [Related]
11. [The principle of hemodilution].
Messmer K; Frey L
Chirurg; 1991 Nov; 62(11):769-74. PubMed ID: 1769256
[No Abstract] [Full Text] [Related]
12. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
13. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
[TBL] [Abstract][Full Text] [Related]
14. [Isovolemic hemodilution in cerebral ischemic attack: clinical and hemorheological evaluation].
Porro F; Curti L; Figini G; Pastori M
Ric Clin Lab; 1989; 19 Suppl 1():113-6. PubMed ID: 2629068
[No Abstract] [Full Text] [Related]
15. [Hemorheology in patients with Raynaud's phenomenon--diagnosis and therapy with plasmapheresis].
Sakriss U; Toussaint C; Turowski A; Schmidt H; Nieter B
Vasa Suppl; 1991; 32():347-9. PubMed ID: 1771530
[No Abstract] [Full Text] [Related]
16. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
17. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
Schmid-Schönbein H
Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
[TBL] [Abstract][Full Text] [Related]
18. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
Rieger H
Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
[No Abstract] [Full Text] [Related]
19. [Hemorheology and hemodilution].
Stoltz JF
Ann Fr Anesth Reanim; 1986; 5(3):193-203. PubMed ID: 3535578
[No Abstract] [Full Text] [Related]
20. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
